BR112018076935A2 - composição, medicamento e método para o tratamento da alopecia induzida por quimioterapia - Google Patents

composição, medicamento e método para o tratamento da alopecia induzida por quimioterapia

Info

Publication number
BR112018076935A2
BR112018076935A2 BR112018076935A BR112018076935A BR112018076935A2 BR 112018076935 A2 BR112018076935 A2 BR 112018076935A2 BR 112018076935 A BR112018076935 A BR 112018076935A BR 112018076935 A BR112018076935 A BR 112018076935A BR 112018076935 A2 BR112018076935 A2 BR 112018076935A2
Authority
BR
Brazil
Prior art keywords
composition
treatment
chemotherapy
drug
induced alopecia
Prior art date
Application number
BR112018076935A
Other languages
English (en)
Inventor
Collett Andrew
Georgopoulos Nikolaos
Paxman Richard
Original Assignee
Paxman Coolers Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paxman Coolers Ltd filed Critical Paxman Coolers Ltd
Publication of BR112018076935A2 publication Critical patent/BR112018076935A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F7/10—Cooling bags, e.g. ice-bags
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F2007/0001—Body part
    • A61F2007/0002—Head or parts thereof
    • A61F2007/0008—Scalp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F7/02—Compresses or poultices for effecting heating or cooling
    • A61F2007/0282—Compresses or poultices for effecting heating or cooling for particular medical treatments or effects
    • A61F2007/0287—Preventing negative effects of chemotherapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Thermal Sciences (AREA)
  • Vascular Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

uma composição para utilização em terapia de resfriamento e tratamento de alopecia quimicamente induzida (cia- chemically induced alopecia), dita composição contendo um inibidor de espécies reativas de oxigênio (ros - reactive oxygen species).
BR112018076935A 2016-06-22 2017-06-20 composição, medicamento e método para o tratamento da alopecia induzida por quimioterapia BR112018076935A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1610910.0A GB201610910D0 (en) 2016-06-22 2016-06-22 Composition and apparatus for treatment of chemotherapy induced alopecia
PCT/GB2017/051804 WO2017220998A1 (en) 2016-06-22 2017-06-20 Composition and apparatus for treatment of chemotherapy induced alopecia

Publications (1)

Publication Number Publication Date
BR112018076935A2 true BR112018076935A2 (pt) 2019-04-02

Family

ID=56895113

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018076935A BR112018076935A2 (pt) 2016-06-22 2017-06-20 composição, medicamento e método para o tratamento da alopecia induzida por quimioterapia

Country Status (8)

Country Link
US (1) US11077088B2 (pt)
EP (1) EP3474792A1 (pt)
JP (1) JP2019524664A (pt)
CN (1) CN109475428B (pt)
BR (1) BR112018076935A2 (pt)
GB (1) GB201610910D0 (pt)
MX (1) MX2018015056A (pt)
WO (1) WO2017220998A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10806626B2 (en) 2015-02-04 2020-10-20 Michael Lynn Zumbrunnen Method and apparatus of a self-managed portable hypothermia system
MX2021014874A (es) 2019-06-03 2022-03-25 Cooler Heads Care Inc Conjunto de gorro de enfriamiento y unidad de enfriamiento.

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4425916A (en) * 1979-06-01 1984-01-17 Therapeutic Products, Inc. Cap structure for creating temperature controlled environment for reducing alopecia
US6150405A (en) * 1985-07-18 2000-11-21 Proctor; Peter H. Hair loss treatment with ascorbates
WO1991014424A1 (en) * 1990-03-28 1991-10-03 Yunis Adel A Methods for protecting against chemotherapy-induced hair loss
CN2206108Y (zh) * 1993-03-23 1995-08-30 钱京朵 促使毛发生长再生的装置
WO1995034303A1 (en) * 1994-06-13 1995-12-21 Arcturus Pharmaceutical Corporation Method for the treatment, prevention or minimization of hair loss
FR2811550B1 (fr) * 2000-07-11 2003-02-14 Oreal Composition a base de vitamines et de sels mineraux, pour diminuer la chute des cheveux et/ou favoriser la repousse des cheveux
AU2001291239A1 (en) * 2000-10-06 2002-04-22 Abbott Laboratories Use of vitamin d2 compounds for alopecia
GB0128809D0 (en) * 2001-12-01 2002-01-23 Paxman Coolers Ltd Cover for cap for cooling human scalp
AU2003256797A1 (en) * 2002-07-31 2004-02-25 Procyte Corporation Compositions containing peptide copper complexes and phytochemical compounds, and methods related thereto
US20080069779A1 (en) * 2003-08-04 2008-03-20 Foamix Ltd. Foamable vehicle and vitamin and flavonoid pharmaceutical compositions thereof
GB2477534A (en) * 2010-02-05 2011-08-10 Ajit Lalvani Composition for the stimulation and regulation of the hair follicle
JP2012193146A (ja) * 2011-03-16 2012-10-11 Oita Univ がん化学療法誘発脱毛に対する抗脱毛用組成物
US20140046410A1 (en) * 2012-08-13 2014-02-13 David Wyatt System and method for avoiding hairloss during chemotherapy

Also Published As

Publication number Publication date
JP2019524664A (ja) 2019-09-05
EP3474792A1 (en) 2019-05-01
WO2017220998A1 (en) 2017-12-28
US20190240192A1 (en) 2019-08-08
MX2018015056A (es) 2019-07-04
CN109475428B (zh) 2022-07-05
CN109475428A (zh) 2019-03-15
US11077088B2 (en) 2021-08-03
GB201610910D0 (en) 2016-08-03

Similar Documents

Publication Publication Date Title
CL2018001226A1 (es) Derivados de dihidroimidazopirazinona usados en el tratamiento del cáncer
BR112018007447A2 (pt) terapia de combinação para tratamento de malignidades
BR112017016019A2 (pt) método para tratamento de câncer, artigo para fabricação, e, kit.
CL2015003442A1 (es) Derivados heterociclicos
BR112017005693A2 (pt) método para tratar e/ou prevenir uma doença hepática, e, composição farmacêutica.
BR112017019738A2 (pt) macrociclos peptidomiméticos e usos dos mesmos
PE20180260A1 (es) Metodos y kits para tratar la depresion
BR112016017700A2 (pt) método para tratamento de um câncer em um indivíduo, medicamento, kit, método, uso ou kit, e, método, medicamento ou kit
EP4282479A3 (en) Use of pridopidine to treat depression or anxiety
BR112018007656A2 (pt) terapia de combinação para tratamento de doenças malignas
AR101312A1 (es) Combinaciones de inhibidores de bet e inhibidores de tirosina quinasa de bruton
EA201790787A1 (ru) Снижение вязкости фармацевтических составов
DOP2017000179A (es) Formulación en polvo nasal para el tratamiento de hipoglicemia
BR112018001853A2 (pt) métodos para tratamento de um distúrbio e para melhoria do tratamento de um distúrbio
MX2015010791A (es) Metodos para tratar el cancer y prevenir la resistencia a farmacos.
TR201901348T4 (tr) Metap-2 inhibitörleri olarak pirolidinon türevleri.
BR112018008882A2 (pt) método para tratar um distúrbio proliferativo e produto farmacêutico
AU2015267099A8 (en) Use of eribulin in the treatment of cancer
BR112018013189A2 (pt) zaragatoa para amostragem bucal e usos da mesma
MX2017013047A (es) Tratamiento de dolor.
BR112018003836A2 (pt) combinações de inibidor de btk para tratar mieloma múltiplo
BR112018068027A2 (pt) método para tratar câncer em um paciente e composição farmacêutica
BR112016025333A2 (pt) agente, produto e uso
CO2017002356A2 (es) Métodos para tratar la depresión usando moduladores de nmda
EA201390287A1 (ru) Теобромин в комбинации с отхаркивающим или муколитическим средствами для применения в терапии

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]